No Data
Xianruida Medical-B (06669.HK) reported a profit of 52.28 million yuan for 2024, representing a year-on-year increase of 260.9%.
On March 24, Glory Exchange announced that, for the fiscal year ending December 31, 2024, the company's revenue is approximately RMB 0.534 billion, an increase of about 12.7% year-on-year. The profit for the year is 52.28 million yuan, an increase of 260.9% year-on-year; earnings per share are 0.17 yuan. In 2024, the company continues to drive innovation and iteration in technology and processes, making significant progress in product development. During the reporting period, three products have completed product finalization, two products are undergoing clinical trials, and six products have submitted registration applications to the National Medical Products Administration.
ACOTEC-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Tell The Story For Acotec Scientific Holdings Limited (HKG:6669) As Its Stock Soars 35%
ACOTEC-B: NOTICE OF BOARD MEETING
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
